Third Rock Ventures

Company news & events

RARE DISEASE DAY

April 12, 2010

Xconomy: Cooking with the Genzyme Recipe: New Players Funding Rare Disease Drugs in Boston

February 11, 2010

Xconomy: Former CombinatoRx CEO Alexis Borisy Lands at Third Rock Ventures, Launches New Startup

July 21, 2009
Third Rock Ventures Expands Team with Biotech Veterans

June 29, 2009
Third Rock Ventures' Initial Three Portfolio Companies are Named
"Fierce 15" Biotechs

Portfolio news & events

Afferent Pharmaceuticals
January 26, 2010 - Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
» Press Release | Company News

Agios Pharmaceuticals
July 29, 2010 - Agios Creates Expanded Scientific Advisory Role for Lewis Cantley, Ph.D.
» Press Release | Company News

Alnara Pharmaceuticals
July 20, 2010 - Lilly Announces Completion of Alnara Acquisition
» Press Release | Company News

Constellation Pharmaceuticals
June 2, 2010 - Constellation Pharmaceuticals Closes $22 Million in Series B Funding
» Press Release | Company News

Eleven Biotherapeutics
February 17, 2010 - Foundation Medicine Created by Cancer Genomics Pioneers to Help Bring Personalized
Cancer Medicine to Routine Clinical Practice
» Press Release | Company News

Foundation Medicine
April 15, 2010 - Foundation Medicine Created by Cancer Genomics Pioneers to Help Bring Personalized
Cancer Medicine to Routine Clinical Practice
» Press Release | Company News

Genetix Pharmaceuticals
August 2, 2010 - Gene makeovers: To treat 2 rare disorders, firm uses defanged HIV virus to get ‘corrected’ genetic material into cells
» Press Release | Company News

Seventh Sense Biosystems
May 20, 2010 - Xconomy: Seventh Sense, Rox Anderson and Bob Langer Startup, Seeks to Collect Blood With No Pain
» Press Release | Company News

Zagfen, Inc.
June 26, 2010 - Zafgen Presents Data on a New Class of Medicines to Treat Obesity at the American Diabetes Association Annual Meeting
» Press Release | Company News